Sophiris Bio Closes Up 69% After Successful Phase 2 Prostate Cancer Results By: TalkMarkets June 10, 2016 at 23:59 PM EDT Injectable localized treatment for prostate cancer shows promising early results. Read More >> Related Stocks: Sophiris Bio